Dr. David J. Levinthal, MD

Dr. Levinthal practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Levinthal's NPI, 1225156961, was assigned on March 27, 2007. Dr. Levinthal graduated from University of Pittsburgh School of Medicine in 2006. Dr. Levinthal holds Pennsylvania license MD435440.

Dr. Levinthal's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Dr. Levinthal's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Levinthal is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Levinthal to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Levinthal practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Levinthal's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Levinthal is licensed in Pennsylvania.

CMS data shows 270 Medicare services from Dr. Levinthal across 12 procedure codes in 2024, for 187 Medicare patients. Medicare paid $17,762 for them.

CMS counts 187 Medicare patients who saw Dr. Levinthal in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Levinthal's median patient age at 60, with 72% women.

In 2024, Dr. Levinthal wrote 2,435 Medicare Part D claims for 206 patients. 83% of them were for generic drugs. CMS names the drug for 2,250 of them, across 53 drugs with 11 or more claims each, at $611,507 in total drug cost. In 2023, CMS named 1,882 claims across 46 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Levinthal for performance year 2024, reported as part of a group. Dr. Levinthal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Levinthal as offering telehealth. CMS counts 44 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Levinthal, more than 61% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 35 papers to Dr. Levinthal, published from 2012 to 2024. 2024 was the busiest year, with 6. The most frequent topics are Vomiting, Neural Pathways and Antiemetics. Dr. Levinthal has published most often in Neurogastroenterol Motil. Dr. Levinthal's most frequent co-authors are Thangam Venkatesan, MD, Klaus Bielefeldt, MD and Camilla A. Richmond, MD.

Dmand AI links Dr. Levinthal to 2 clinical trials. Conditions studied include Familial cyclic vomiting syndrome, Irritable Bowel Syndrome and Colonic Diseases, Functional.

CMS Open Payments shows 34 general payments to Dr. Levinthal from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 92% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $24,037. It also lists 7 research payments totaling $7,755 from 2020 to 2025.

Dr. Levinthal graduated from University of Pittsburgh School of Medicine in 2006.